AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Drug Makers Mostly Immune to Cooling Economic Conditions, Analysts Say.
Byline: Lewis Krauskopf
Apr. 12--As the economy cools, buying that new PC can wait, but getting your medicine often can't.
That underlying premise has analysts predicting that most large drug makers will continue to post double-digit profit growth rates this quarter, despite a change in economic conditions that is causing some companies in other industries to flounder.
"Unlike other sectors, consumers are not able to delay the purchase of pharmaceuticals," said Mario Corso, an industry analyst at the firm ABN Amro. "The pharmaceutical industry is insulated in that regard."
A group of about 30 small, midsize, and large pharmaceutical companies are expected by …
-
- New Jersey-Based Pharmaceutical Firms Weather Tough Times.
-
Newspaper article from: The Record (Bergen County, NJ)
October 12, 2001
700+ words
-
- IBD'S TOP 10.(A)
-
Magazine article from: Investor's Business Daily
August 9, 2001
700+ words
-
- Smaller Mergers Reshape Pharmaceutical Firms in First Half of 2001.
-
Newspaper article from: The Record (Bergen County, NJ)
October 7, 2001
700+ words
-
- World: Wall Street dips on rebounding oil, earning reports.
-
News wire article from: Thai Press Reports
July 24, 2008
700+ words
-
- Acquisition Drivers Accumulate In a Market Stymied by Uncertainty.
-
Magazine article from: Mergers & Acquisitions: The Dealmaker's Journal
Harrison, Joan
March 1, 2003
700+ words
